NGM Biopharmaceuticals Q4 EPS $(0.33) Beats $(0.39) Estimate, Sales $165.00K Miss $560.00K Estimate

NGM Biopharmaceuticals (NASDAQ:NGM) reported quarterly losses of $(0.33) per share which beat the analyst consensus estimate of $(0.39) by 15.38 percent. This is a 26.67 percent increase over losses of $(0.45) per share from the same period last year. The company reported quarterly sales of $165.00 thousand which missed the analyst consensus estimate of $560.00 thousand by 70.54 percent. This is a 99.09 percent decrease over sales of $18.18 million the same period last year.